In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Medical Devices Technical
Corrections Act''.

SEC. 2. TECHNICAL CORRECTIONS REGARDING PUBLIC LAW 107-250.

(a) Title I; Fees Relating to Medical Devices.--Part 3 of
subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 379i et seq.), as added by section 102 of Public Law 107-250
(116 Stat. 1589), is amended--
(1) in section 737--
(A) in paragraph (4)(B), by striking ''and for which
clinical data are generally necessary to provide a reasonable
assurance of safety and effectiveness'' and inserting ''and for
which substantial clinical data are necessary to provide a
reasonable assurance of safety and effectiveness'';
(B) in paragraph (4)(D), by striking ''manufacturing,'';
(C) in paragraph (5)(J), by striking ''a premarket
application'' and all that follows and inserting ''a premarket
application or premarket report under section 515 or a
premarket application under section 351 of the Public Health
Service Act.''; and
(D) in paragraph (8), by striking ''The term 'affiliate'
means a business entity that has a relationship with a second
business entity'' and inserting ''The term 'affiliate' means a
business entity that has a relationship with a second business
entity (whether domestic or international)''; and
(2) in section 738--
(A) in subsection (a)(1)--
(i) in subparagraph (A)--

(I) in the matter preceding clause (i) by striking
''subsection (d),'' and inserting ''subsections (d) and
(e),'';
(II) in clause (iv), by striking ''clause (i),''
and all that follows and inserting ''clause (i).''; and
(III) in clause (vii), by striking ''clause (i),''
and all that follows and inserting ''clause (i),
subject to any adjustment under subsection
(e)(2)(C)(ii).''; and

(ii) in subparagraph (D), in each of clauses (i) and
(ii), by striking ''application'' and inserting
''application, report,'';
(B) in subsection (d)(2)(B), beginning in the second
sentence, by striking ''firms. which show'' and inserting
''firms, which show'';
(C) in subsection (e)--
(i) in paragraph (1), by striking ''Where'' and
inserting ''For fiscal year 2004 and each subsequent fiscal
year, where''; and
(ii) in paragraph (2)--

(I) in subparagraph (B), beginning in the second
sentence, by striking ''firms. which show'' and
inserting ''firms, which show''; and
(II) in subparagraph (C)(i), by striking ''Where''
and inserting ''For fiscal year 2004 and each
subsequent fiscal year, where'';

(D) in subsection (f), by striking ''for filing''; and
(E) in subsection (h)(2)(B)--
(i) in clause (ii), by redesignating subclauses (I) and
(II) as items (aa) and (bb), respectively;
(ii) by redesignating clauses (i) and (ii) as
subclauses (I) and (II), respectively;
(iii) by striking ''The Secretary'' and inserting the
following:
''(i) In general.--The Secretary''; and
(iv) by adding at the end the following:
''(ii) More than 5 percent.--To the extent such costs
are more than 5 percent below the specified level in
subparagraph (A)(ii), fees may not be collected under this
section for that fiscal year.''.
(b) Title II; Amendments Regarding Regulation of Medical Devices.--
(1) Inspections by accredited persons.--Section 704(g) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374(g)), as added
by section 201 of Public Law 107-250 (116 Stat. 1602), is amended--
(A) in paragraph (1), in the first sentence, by striking
''conducting inspections'' and all that follows and inserting
''conducting inspections of establishments that manufacture,
prepare, propagate, compound, or process class II or class III
devices, which inspections are required under section 510(h) or
are inspections of such establishments required to register
under section 510(i).'';
(B) in paragraph (5)(B), in the first sentence, by striking
''or poses'' and all that follows through the period and
inserting ''poses a threat to public health, fails to act in a
manner that is consistent with the purposes of this subsection,
or where the Secretary determines that there is a financial
conflict of interest in the relationship between the accredited
person and the owner or operator of a device establishment that
the accredited person has inspected under this subsection.'';
(C) in paragraph (6)(A)--
(i) in clause (i), by striking ''of the establishment
pursuant to subsection (h) or (i) of section 510'' and
inserting ''described in paragraph (1)'';
(ii) in clause (ii)--

(I) in the matter preceding subclause (I)--

(aa) by striking ''each inspection'' and
inserting ''inspections''; and
(bb) by inserting ''during a 2-year period''
after ''person''; and

(II) in subclause (I), by striking ''such a
person'' and inserting ''an accredited person'';

(iii) in clause (iii)--

(I) in the matter preceding subclause (I), by
striking ''and the following additional conditions are
met:'' and inserting ''and 1 or both of the following
additional conditions are met:'';
(II) in subclause (I), by striking ''accredited''
and all that follows through the period and inserting
''(accredited under paragraph (2) and identified under
clause (ii)(II)) as a person authorized to conduct such
inspections of device establishments.''; and
(III) in subclause (II), by inserting ''or by a
person accredited under paragraph (2)'' after ''by the
Secretary'';

(iv) in clause (iv)(I)--

(I) in the first sentence--

(aa) by striking ''the two immediately
preceding inspections of the establishment'' and
inserting ''inspections of the establishment during
the previous 4 years''; and
(bb) by inserting ''section'' after ''pursuant
to'';

(II) in the third sentence--

(aa) by striking ''the petition states a
commercial reason for the waiver;''; and
(bb) by inserting ''not'' after ''the Secretary
has not determined that the public health would'';
and

(III) in the fourth sentence, by striking ''granted
until'' and inserting ''granted or deemed to be granted
until''; and

(v) in clause (iv)(II)--

(I) by inserting ''of a device establishment
required to register'' after ''to be conducted''; and
(II) by inserting ''section'' after ''pursuant
to'';

(D) in paragraph (6)(B)(iii)--
(i) in the first sentence, by striking '', and data
otherwise describing whether the establishment has
consistently been in compliance with sections 501 and 502
and other'' and inserting ''and with other''; and
(ii) in the second sentence--

(I) by striking ''inspections'' and inserting
''inspectional findings''; and
(II) by inserting ''relevant'' after ''together
with all other'';

(E) in paragraph (6)(B)(iv)--
(i) by inserting ''(I)'' after ''(iv)''; and
(ii) by adding at the end the following:
''(II) If, during the two-year period following clearance under
subparagraph (A), the Secretary determines that the device
establishment is substantially not in compliance with this Act, the
Secretary may, after notice and a written response, notify the
establishment that the eligibility of the establishment for the
inspections by accredited persons has been suspended.'';
(F) in paragraph (6)(C)(ii), by striking ''in accordance
with section 510(h), or has not during such period been
inspected pursuant to section 510(i), as applicable'';
(G) in paragraph (10)(B)(iii), by striking ''a reporting''
and inserting ''a report''; and
(H) in paragraph (12)--
(i) by striking subparagraph (A) and inserting the
following:
''(A) the number of inspections conducted by accredited persons
pursuant to this subsection and the number of inspections conducted
by Federal employees pursuant to section 510(h) and of device
establishments required to register under section 510(i);''; and
(ii) in subparagraph (E), by striking ''obtained by the
Secretary'' and all that follows and inserting ''obtained
by the Secretary pursuant to inspections conducted by
Federal employees;''.
(2) Other corrections.--
(A) Prohibited acts.--Section 301(gg) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 331(gg)), as amended by
section 201(d) of Public Law 107-250 (116 Stat. 1609), is
amended to read as follows:
''(gg) The knowing failure to comply with paragraph (7)(E) of
section 704(g); the knowing inclusion by a person accredited under
paragraph (2) of such section of false information in an inspection
report under paragraph (7)(A) of such section; or the knowing failure
of such a person to include material facts in such a report.''.
(B) Electronic labeling.--Section 502(f) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 352(f)), as amended by
section 206 of Public Law 107-250 (116 Stat. 1613), is amended,
in the last sentence--
(i) by inserting ''or by a health care professional and
required labeling for in vitro diagnostic devices intended
for use by health care professionals or in blood
establishments'' after ''in health care facilities'';
(ii) by inserting a comma after ''means'';
(iii) by striking ''requirements of law and, that'' and
inserting ''requirements of law, and that'';
(iv) by striking ''the manufacturer affords health care
facilities the opportunity'' and inserting ''the
manufacturer affords such users the opportunity''; and
(v) by striking ''the health care facility''.
(c) Title III; Additional Amendments.--
(1) Effective date.--Section 301(b) of Public Law 107-250 (116
Stat. 1616), is amended by striking ''18 months'' and inserting
''36 months''.
(2) Premarket notification.--Section 510(o) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 360(o)), as added by
section 302(b) of Public Law 107-250 (116 Stat. 1616), is amended--
(A) in paragraph (1)(B), by striking '', adulterated'' and
inserting ''or adulterated''; and
(B) in paragraph (2)--
(i) in subparagraph (B), by striking '', adulterated''
and inserting ''or adulterated''; and
(ii) in subparagraph (E), by striking ''semicritical''
and inserting ''semi-critical''.
(d) Miscellaneous Corrections.--
(1) Certain amendments to section 515.--
(A) In general.--
(i) Technical correction.--Section 515(c) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e(c)),
as amended by sections 209 and 302(c)(2)(A) of Public Law
107-250 (116 Stat. 1613, 1618), is amended by redesignating
paragraph (3) (as added by section 209 of such Public Law)
as paragraph (4).
(ii) Modular review.--Section 515(c)(4)(B) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360e(c)(4)(B)) is amended by striking ''unless an issue of
safety'' and inserting ''unless a significant issue of
safety''.
(B) Conforming amendment.--Section 210 of Public Law 107-
250 (116 Stat. 1614) is amended by striking
'', as amended'' and all that follows through ''by adding'' and
inserting ''is amended in paragraph (3), as redesignated by
section 302(c)(2)(A) of this Act, by adding''.
(2) Certain amendments to section 738.--
(A) In general.--Section 738(a) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 379j(a)), as amended by subsection
(a), is amended--
(i) in the matter preceding paragraph (1)--

(I) by striking ''(a) Types of Fees.--Beginning
on'' and inserting the following:

''(a) Types of Fees.--
''(1) In general.--Beginning on''; and

(II) by striking ''this section as follows:'' and
inserting ''this section.''; and

(ii) by striking ''(1) Premarket application,'' and
inserting the following: ''(2) Premarket application,''.
(B) Conforming amendments.--Section 738 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 379j), as amended by
subparagraph (A), is amended--
(i) in subsection (d)(1), in the last sentence, by
striking ''subsection (a)(1)(A)'' and inserting
''subsection (a)(2)(A)'';
(ii) in subsection (e)(1), by striking ''subsection
(a)(1)(A)(vii)'' and inserting ''subsection
(a)(2)(A)(vii)'';
(iii) in subsection (e)(2)(C)--

(I) in each of clauses (i) and (ii), by striking
''subsection (a)(1)(A)(vii)'' and inserting
''subsection (a)(2)(A)(vii)''; and
(II) in clause (ii), by striking ''subsection
(a)(1)(A)(i)'' and inserting ''subsection
(a)(2)(A)(i)''; and

(iv) in subsection (j), by striking ''subsection
(a)(1)(D),'' and inserting ''subsection (a)(2)(D),''.
(C) Additional conforming amendment.--Section 102(b)(1) of
Public Law 107-250 (116 Stat. 1600) is amended, in the matter
preceding subparagraph (A), by striking ''section
738(a)(1)(A)(ii)'' and inserting ''section 738(a)(2)(A)(ii)''.
(3) Public law 107-250.--Public Law 107-250 is amended--
(A) in section 102(a) (116 Stat. 1589), by striking ''(21
U.S.C. 379F et seq.)'' and inserting ''(21 U.S.C. 379f et
seq.)'';
(B) in section 102(b) (116 Stat. 1600)--
(i) by striking paragraph (2);
(ii) in paragraph (1), by redesignating subparagraphs
(A) and (B) as paragraphs (1) and (2), respectively; and
(iii) by striking:
''(b) Fee Exemption for Certain Entities Submitting Premarket
Reports.--
''(1) In general.--A person submitting a premarket report'' and
inserting:
''(b) Fee Exemption for Certain Entities Submitting Premarket
Reports.--A person submitting a premarket report''; and
(C) in section 212(b)(2) (116 Stat. 1614), by striking '',
such as phase IV trials,''.
SEC. 3. REPORT ON BARRIERS TO AVAILABILITY OF DEVICES INTENDED FOR
CHILDREN.
Not later than 180 days after the date of enactment of this Act,
the Secretary of Health and Human Services shall submit to the
Committee on Health, Education, Labor, and Pensions of the Senate and
the Committee on Energy and Commerce of the House of Representatives a
report on the barriers to the availability of devices intended for the
treatment or diagnosis of diseases and conditions that affect children.
The report shall include any recommendations of the Secretary of Health
and Human Services for changes to existing statutory authority,
regulations, or agency policy or practice to encourage the invention
and development of such devices.

Speaker of the House of Representatives.

Vice President of the United States and
President of the Senate.
Example Output: Medical Devices Technical Corrections Act - Amends the Federal Food, Drug, and Cosmetic Act (as amended by the Medical Device User Fee and Modernization Act of 2002) to revise provisions concerning medical devices user fees.

Prohibits the Secretary of Health and Human Services from collecting fees to defray costs in any fiscal year where the amount appropriated is more than five percent below the costs of the resources allocated for the review of device applications.

Allows the Secretary to withdraw accreditation to inspect from any person where the Secretary determines that there is a conflict of interest between the company and the accredited inspector.

Permits a company that markets at least one medical device in the United States and one medical device in another country to use an accredited third party inspector if the company certifies that the foreign country recognizes inspections by: (1) the Food and Drug Administration (FDA); and/or (2) the third party inspector. (Current law requires a country to recognize both types of inspections.)

Allows the Secretary to withdraw eligibility for third party inspections from a company if the Secretary determines that the company is substantially not in compliance with the Act.

Allows electronic labeling for prescription devices intended for use by health care professionals and for in vitro diagnostic devices intended for use by health care professionals or in blood establishments.

Delays by 18 additional months the effective date of the provision deeming a device misbranded if the identification of the manufacturer is not conspicuously displayed.

Directs the Secretary to submit a report to the relevant committees on the barriers to the availability of devices intended for treatment or diagnosis of diseases or conditions that affect children.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Muhammad Ali Commemorative Coin
Act''.

SEC. 2. FINDINGS.

Congress finds that--
(1) Muhammad Ali was an Olympic gold medalist, 3-time World
Heavyweight Champion boxer, and one of the most celebrated and
well-known athletes in American history;
(2) Muhammad Ali showed, beyond his impressive fighting
prowess in the boxing ring, even greater courage and tenacity
as an advocate outside the ring;
(3) Muhammad Ali was a great philanthropist and a strong
champion of peace, equality, and freedom;
(4) Muhammad Ali remains an icon of freedom of conscience;
(5) Muhammad Ali was a prominent African American of the
Muslim faith, and was, and continues to be, a role model to the
citizens of the United States of all races, ethnicities, and
religions;
(6) Muhammad Ali used his fame to advocate for humanitarian
causes in audiences with world leaders ranging from religious
leaders to heads of state; and
(7) Muhammad Ali inspired people around the globe in
displaying the same vibrant and larger-than-life character and
dedication in spite of his physical ailments.

SEC. 3. COIN SPECIFICATIONS.

(a) Denominations.--The Secretary of the Treasury (hereafter in
this Act referred to as the ''Secretary'') shall mint and issue the
following coins in commemoration of Muhammad Ali:
(1) $5 gold coins.--Not more than 100,000 $5 coins, which
shall--
(A) weigh 8.359 grams;
(B) have a diameter of 0.850 inches; and
(C) contain 90 percent gold and 10 percent alloy.
(2) $1 silver coins.--Not more than 350,000 $1 coins, which
shall--
(A) weigh 26.73 grams;
(B) have a diameter of 1.500 inches; and
(C) contain not less than 90 percent silver.
(b) Legal Tender.--The coins minted under this Act shall be legal
tender, as provided in section 5103 of title 31, United States Code.
(c) Numismatic Items.--For purposes of section 5134 and 5136 of
title 31, United States Code, all coins minted under this Act shall be
considered to be numismatic items.

SEC. 4. DESIGN OF COINS.

(a) Design Requirements.--
(1) In general.--The design of the coins minted under this
Act shall be emblematic of the life and legacy of Muhammad Ali.
(2) Design and inscriptions.--On each coin minted under
this Act there shall be--
(A) a designation of the value of the coin;
(B) an inscription of the year 2020; and
(C) inscriptions of the words ''Liberty'', ''In God
We Trust'', ''United States of America'', and ''E
Pluribus Unum''.
(b) Selection.--The design for the coins minted under this Act
shall be--
(1) selected by the Secretary after consultation with the
Muhammad Ali Center; and
(2) reviewed by the Citizens Coinage Advisory Committee.

SEC. 5. ISSUANCE OF COINS.

(a) Quality of Coins.--Coins minted under this Act shall be issued
in uncirculated and proof qualities.
(b) Mint Facility.--Only 1 facility of the United States Mint may
be used to strike any particular quality of the coins minted under this
Act.
(c) Period for Issuance.--The Secretary may issue coins minted
under this Act only during the 1-year period beginning on January 1,
2020.

SEC. 6. SALE OF COINS.

(a) Sale Price.--The coins issued under this Act shall be sold by
the Secretary at a price equal to the sum of--
(1) the face value of the coins;
(2) the surcharge provided in section 7(a) with respect to
such coins; and
(3) the cost of designing and issuing the coins (including
labor, materials, dies, use of machinery, overhead expenses,
marketing, and shipping).
(b) Bulk Sales.--The Secretary shall make bulk sales of the coins
issued under this Act at a reasonable discount.
(c) Prepaid Orders.--
(1) In general.--The Secretary shall accept prepaid orders
for the coins minted under this Act before the issuance of such
coins.
(2) Discount.--Sale prices with respect to prepaid orders
under paragraph (1) shall be at a reasonable discount.

SEC. 7. SURCHARGES.

(a) In General.--All sales of coins issued under this Act shall
include a surcharge of--
(1) $35 per coin for the $5 coin; and
(2) $10 per coin for the $1 coin.
(b) Distribution.--Subject to section 5134(f)(1) of title 31,
United States Code, all surcharges received by the Secretary from the
sale of coins issued under this Act shall be promptly paid by the
Secretary as follows:
(1) Eighty percent of the surcharges shall be paid to the
Muhammad Ali Center in Louisville, Kentucky, to ensure growth
and innovation in museum programming to research, promote, and
educate on the legacy of Muhammad Ali.
(2) Ten percent of the surcharges shall be paid to the
Muhammad Ali Institute for Peace and Justice at the University
of Louisville to advance the work, study and practice of
peacebuilding, social justice, and violence prevention through
the development of innovative educational programs, training,
service, and research.
(3) Ten percent of the surcharges shall be paid to the
Muhammad Ali Parkinson Center (MAPC) and Movement Disorder
Clinic to continue serving as a resource for Parkinson's
disease patients and their families through the provision of
diagnosis, treatments, research, and education.
(c) Audit.--The Comptroller General of the United States shall have
the right to examine such books, records, documents, and other data of
each of the organizations referred to in subsection (b) as may be
related to the expenditures of amounts paid under that subsection.
(d) Limitations.--Notwithstanding subsection (a), no surcharge may
be included with respect to the issuance under this Act of any coin
during a calendar year if, as of the time of such issuance, the
issuance of such coin would result in the number of commemorative coin
programs issued during such year to exceed the annual 2 commemorative
coin program issuance limitation under section 5112(m)(1) of title 31,
United States Code (as in effect on the date of the enactment of this
Act). The Secretary of the Treasury may issue guidance to carry out
this subsection.
Example Output: Muhammad Ali Commemorative Coin Act This bill requires the Department of the Treasury to mint and issue commemorative coins that emblemize the life and legacy of Muhammad Ali. Surcharges received from the sale of these coins shall be paid to: (1) the Muhammad Ali Center in Louisville, Kentucky; (2) the Muhammad Ali Institute for Peace and Justice at the University of Louisville; and (3) the Muhammad Ali Parkinson Center and Movement Disorder Clinic.

Example Input: SECTION 1. ESTABLISHING A SINGLE STANDARDIZED AMOUNT UNDER MEDICARE
INPATIENT HOSPITAL PPS.

(a) In General.--Section 1886(d)(3)(A) of the Social Security Act
(42 U.S.C. 1395ww(d)(3)(A)) is amended--
(1) in clause (iv), by inserting ''and ending on or before
September 30, 2001,'' after ''October 1, 1995,''; and
(2) by redesignating clauses (v) and (vi) as clauses (vii)
and (viii), respectively, and inserting after clause (iv) the
following new clauses:
''(v) For discharges occurring in the fiscal year beginning
on October 1, 2001, the average standardized amount for
hospitals located in areas other than a large urban area shall
be equal to the average standardized amount for hospitals
located in a large urban area.
''(vi) For discharges occurring in a fiscal year beginning
on or after October 1, 2002, the Secretary shall compute an
average standardized amount for hospitals located in all areas
within the United States equal to the average standardized
amount computed under clause (v) or this clause for the
previous fiscal year increased by the applicable percentage
increase under subsection (b)(3)(B)(i) for the fiscal year
involved.''.
(b) Conforming Amendments.--
(1) Update factor.--Section 1886(b)(3)(B)(i)(XVII) of the
Social Security Act (42 U.S.C. 1395ww(b)(3)(B)(i)(XVII)) is
amended by striking ''for hospitals in all areas,'' and
inserting ''for hospitals located in a large urban area,''.
(2) Computing drg-specific rates.--
(A) In general.--Section 1886(d)(3)(D) of such Act
(42 U.S.C. 1395ww(d)(3)(D)) is amended--
(i) in the heading by striking ''in
different areas'';
(ii) in the matter preceding clause (i)--
(I) by inserting ''for fiscal years
before fiscal year 1997'' before ''a
regional DRG prospective payment rate
for each region,''; and
(II) by striking ''each of which
is'';
(iii) in clause (i)--
(I) by inserting ''for fiscal years
before fiscal year 2002,'' after
''(i)''; and
(II) by striking ''and'' at the
end;
(iv) in clause (ii)--
(I) by inserting ''for fiscal years
before fiscal year 2002,'' after
''(ii)''; and
(II) by striking the period at the
end and inserting ''; and''; and
(v) by adding at the end the following new
clause:
''(iii) for a fiscal year beginning after fiscal
year 2001, for hospitals located in all areas, to the
product of--
''(I) the applicable average standardized
amount (computed under subparagraph (A)),
reduced under subparagraph (B), and adjusted or
reduced under subparagraph (C) for the fiscal
year; and
''(II) the weighting factor (determined
under paragraph (4)(B)) for that diagnosis-
related group.''.
(B) Technical conforming sunset.--Section
1886(d)(3) of such Act (42 U.S.C. 1395ww(d)(3)) is
amended in the matter preceding subparagraph (A) by
inserting ''for fiscal years before fiscal year 1997''
before ''a regional DRG prospective payment rate''.

SEC. 2. FLOOR ON AREA WAGE ADJUSTMENT FACTORS USED UNDER MEDICARE PPS
FOR INPATIENT AND OUTPATIENT HOSPITAL SERVICES.

(a) Inpatient PPS.--Section 1886(d)(3)(E) of the Social Security
Act (42 U.S.C. 1395ww(d)(3)(E)) is amended--
(1) by inserting ''(i) In general.--'' before ''The
Secretary'', and adjusting the margin two ems to the right;
(2) by striking ''The Secretary'' and inserting ''Subject
to clause (ii), the Secretary''; and
(3) by adding at the end the following:
''(ii) Floor on area wage adjustment factor.--
Notwithstanding clause (i), in determining payments
under this subsection for discharges occurring on or
after October 1, 2001, the Secretary shall substitute a
factor of .925 for any factor that would otherwise
apply under such clause that is less than .925. Nothing
in this clause shall be construed as authorizing--
''(I) the application of the last sentence
of clause (i) to any substitution made pursuant
to this clause, or
''(II) the application of the preceding
sentence of this clause to adjustments for area
wage levels made under other payment systems
established under this title (other than the
payment system under section 1833(t)) to which
the factors established under clause (i)
apply.''.
(b) Outpatient PPS.--Section 1833(t)(2) of the Social Security Act
(42 U.S.C. 1395l(t)(2)) is amended by adding at the end the following:
''For purposes of subparagraph (D) for items and services furnished on
or after October 1, 2001, if the factors established under clause (i)
of section 1886(d)(3)(E) are used to adjust for relative differences in
labor and labor-related costs under the payment system established
under this subsection, the provisions of clause (ii) of such section
(relating to a floor on area wage adjustment factor) shall apply to
such factors, as used in this subsection, in the same manner and to the
same extent (including waiving the applicability of the requirement for
such floor to be applied in a budget neutral manner) as they apply to
factors under section 1886.''.
Example Output:
Amends title XVIII (Medicare) of the Social Security Act (SSA) to: (1) mandate a single national average standardized payment amount for inpatient hospital services furnished, regardless of whether in an urban or non-urban area, under the Medicare prospective payment system (PPS) for discharges occurring in FY 2002 and thereafter; and (2) establish a minimum factor of .925 as a floor for area wage adjustment factors used under the PPS for inpatient and outpatient hospital services.